haematology
Public health

Stem cell transplant and CAR T-cell patients should be first for COVID vaccine

The benefits of COVID-19 vaccination outweigh the unknown risks in haematopoietic stem cell transplant and CAR T-cell (TCT) patients. According to the Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) consensus position statement, there are currently no studies evaluating COVID-19 vaccines in TCT patients. “Despite the lack of data, there is no immunologic rationale ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic